SoftBank eyes smaller bets, bigger returns in Vision Fund rethink

Japanese investment vehicle steps away from winner-takes-all playbook

20201102  BiovitalsHF_App

The Vision Fund's $100 million backing for Biofourmis, a U.S. startup that tracks health data using wearable devices, highlights its new focus on early-stage investments. (Photo courtesy of Biofourmis)

WATARU SUZUKI, Nikkei staff writer and CHRISTOPHER GRIMES, executive editor

TOKYO -- SoftBank Group's Vision Fund is turning to a new strategy as a global pandemic and government stimulus distort tech valuations: Invest smaller in hopes for bigger returns.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.